Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIMI Regulatory News (IMI)

Share Price Information for IMI (IMI)

Share Price is delayed by 15 minutes
Get Live Data
2,828.00    18.00 (0.64%)
Bid:
2,828.00
Ask:
2,832.00
Spread: 4.00 (0.141%)
Market Cap: £6.73b
IMI Live PriceLast checked at - London Stock Exchange

Intraday IMI Share Chart

Trading Update

12 May 2026 07:00

RNS Number : 8526D
IMI PLC
12 May 2026
 

12 May 2026

 

Good first quarter performance

On track to deliver a sixth consecutive year of mid-single-digit organic revenue growth

Full year guidance reconfirmed

 

IMI plc ("IMI"), a global leader in fluid and motion control, issues the following trading update which covers results for the first quarter from 1 January to 31 March 2026.

 

Roy Twite, Chief Executive, commented:

 

"We have made a good start to the year, delivering organic growth across IMI in the first quarter. Our performance reflects the strength of the One IMI operating model and the benefits of our strategic focus on three megatrends - Energy, Automation and Healthcare - which are creating sustained demand across our markets and underpinning our long-term growth.

 

We are pleased to be reconfirming our fullyear guidance and remain on track to deliver our sixth consecutive year of midsingle-digit organic revenue growth in 2026.

 

We are actively monitoring the situation in the Middle East, where the safety of our people remains our top priority. The region represented 6% of IMI's revenue in 2025, principally within Process Automation.

 

IMI remains well positioned, with a unique market-led approach to innovation, significant recurring high-margin aftermarket exposure and strong pricing power. Our strong balance sheet and significant cash generation continue to support investment, shareholder returns and strategic flexibility."

 

First quarter performance

 

First quarter organic revenue was 5% higher year on year. Statutory revenue in the quarter was 6% higher than last year, reflecting foreign currency movements in the period.

 

Automation

 

Automation (65% of 2025 sales) delivered organic revenue growth of 6% in the quarter.

 

· Process Automation (44% of 2025 sales) organic revenue was up 6% in the period. As expected, total orders were down 2% organically year-on-year, against a strong comparator. Aftermarket orders declined by 1%, reflecting several large nuclear Aftermarket orders won in the first quarter of last year as previously highlighted. Whilst the conflict in the Middle East did lead to some disruption in the region during the first quarter, the effect on orders and sales was not significant. We continue to see a strong pipeline of global opportunities, driven by the rapidly increasing demand for energy from data centres and widespread electrification.

 

· Industrial Automation (21% of 2025 sales) organic revenue increased by 6% year on year, benefiting from an easier comparator following the cyber incident in the first quarter of 2025. Industrial Automation is expected to be modestly higher organically in 2026.

 

Life Technology

 

Life Technology (35% of 2025 sales) organic revenue increased by 4% in the first quarter.

 

· Climate Control (18% of 2025 sales) organic revenue grew by 4% compared to the same period last year. Demand for energyefficient solutions remained supportive, including continued strength in the data centre direct liquid cooling market.

 

· Life Science and Fluid Control (10% of 2025 sales) organic revenue increased by 1% in the first quarter. Growth in Life Science was supported by resilient healthcare demand and further signs of stabilisation in the global life science device market. This was partially offset by the impact of mixed market conditions in Fluid Control.

 

· Transport (7% of 2025 sales) organic revenue was 9% higher year on year, in line with the heavyduty truck market. The strategic review of Transport is progressing; we are delivering significant operational improvements and continue to assess all strategic options.

 

Exchange rates

 

If exchange rates as at 1 May 2026 of US$1.36 and €1.16 remain constant for the remainder of the year, it would have no material impact on revenue and adjusted operating profit in the full year when compared to 2025.

 

Full year guidance reconfirmed

 

Following the good first quarter performance, we are reconfirming our full year guidance and remain on track to deliver our sixth consecutive year of mid-single-digit organic revenue growth in 2026. We continue to expect that full year adjusted basic earnings per share will be between 136p and 142p.

 

Our guidance assumes that conditions allow for planned shipments to the Middle East to be delivered by the end of the financial year. Whilst we remain alert to the potential indirect impact of the conflict, we expect to manage any inflationary pressures through price increases where necessary.

 

Half-year results

 

IMI will present its half-year results for the period ending 30 June 2026 on 31 July 2026.

 

Enquiries to:

 

Edward Hann

IMI

Tel: +44 (0)7977 354 810

Faeth Birch

FGS Global

Tel: +44 (0)7768 943 171

James Gray

FGS Global

Tel: +44 (0)7814 379 412

IMI-UK@fgsglobal.com

 

A conference call for analysts and investors will be held at 08:00 BST today to discuss this statement. To access the call, please register using the link:

 

https://www.netroadshow.com/events/login/1PeTHmohVhEQqO7QvJPq5Kz1eqlYHIsGbuaVE

 

 

 

 

Notes

 

IMI plc is a global leader in fluid and motion control. Its innovative solutions, built around valves and actuators, enable vital sectors to become safer, more productive and more energy efficient. IMI combines world-class applications engineering expertise with a continued focus on commercial excellence, market-led innovation and continuous improvement to solve its customers' most acute engineering problems. IMI employs approximately 10,000 people, has manufacturing facilities in 18 countries and operates a global service network. IMI is a member of the FTSE 100 and is listed on the London Stock Exchange. Further information is available at www.imiplc.com.

 

References to adjusted figures reflect figures as reported to management and do not include the impact of adjusting items. References to organic changes are on a constant currency basis and exclude disposals and acquisitions.

 

IMI plc is registered in England No. 714275. Its legal entity identifier ('LEI') number is 2138002W9Q21PF751R30.

 

Brand materials can be found here.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTAKDBKPBKDDPD
Date   Source Headline
24th Apr 201711:37 amRNSDirector/PDMR Shareholding
12th Apr 201712:25 pmRNSDirector/PDMR Shareholding
6th Apr 20172:52 pmRNSDirector/PDMR Shareholding
6th Apr 201711:13 amRNSHolding(s) in Company
3rd Apr 20179:43 amRNSTotal Voting Rights
24th Mar 201710:28 amRNSAnnual Financial Report
15th Mar 20172:33 pmRNSDirector/PDMR Shareholding
9th Mar 20172:27 pmRNSDirector/PDMR Shareholding
1st Mar 201710:53 amRNSTotal Voting Rights
27th Feb 201711:00 amRNSDirector Declaration
24th Feb 20177:00 amRNSPreliminary results, year ended 31 December 2016
15th Feb 20172:00 pmRNSDirector/PDMR Shareholding
1st Feb 201710:11 amRNSTotal Voting Rights
13th Jan 20173:25 pmRNSBlock listing Interim Review
11th Jan 20173:22 pmRNSDirector/PDMR Shareholding
3rd Jan 201712:01 pmRNSTotal Voting Rights
14th Dec 20163:54 pmRNSDirector/PDMR Shareholding
1st Dec 201610:39 amRNSTotal Voting Rights
24th Nov 201611:13 amRNSDirector/PDMR Shareholding
10th Nov 20167:00 amRNSIMI plc Interim Management Statement
9th Nov 20163:20 pmRNSDirector/PDMR Shareholding
1st Nov 20169:07 amRNSTotal Voting Rights
12th Oct 20164:03 pmRNSDirector/PDMR Shareholding
3rd Oct 201611:04 amRNSTotal Voting Rights
19th Sep 20163:12 pmRNSDirector/PDMR Shareholding
14th Sep 20163:12 pmRNSDirector/PDMR Shareholding
2nd Sep 20164:20 pmRNSTotal Voting Rights
10th Aug 20163:03 pmRNSDirector/PDMR Shareholding
1st Aug 201611:33 amRNSTotal Voting Rights
29th Jul 20167:00 amRNSInterim results, six months ended 30 June 2016
13th Jul 20163:57 pmRNSDirector/PDMR Shareholding
4th Jul 201610:52 amRNSBlock listing Interim Review
1st Jul 20162:10 pmRNSTotal Voting Rights
15th Jun 20162:35 pmRNSDirector/PDMR Shareholding
1st Jun 201610:26 amRNSTotal Voting Rights
26th May 20163:03 pmRNSDirector/PDMR Shareholding
25th May 20164:02 pmRNSDirector/PDMR Shareholding
23rd May 20164:18 pmRNSDirector/PDMR Shareholding
11th May 20163:36 pmRNSDirector/PDMR Shareholding
5th May 20162:48 pmRNSResult of AGM
5th May 20162:39 pmRNSDirector Declaration
5th May 20167:00 amRNSInterim Management Statement
3rd May 201610:04 amRNSTotal Voting Rights
29th Apr 20162:17 pmRNSDirector/PDMR Shareholding
13th Apr 201612:26 pmRNSDirector/PDMR Shareholding
1st Apr 20162:35 pmRNSHolding(s) in Company
1st Apr 201610:04 amRNSTotal Voting Rights
23rd Mar 20164:22 pmRNSAnnual Financial Report
9th Mar 20164:50 pmRNSDirector/PDMR Shareholding
1st Mar 201610:14 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.